Blend Labs (BLND) Insider Sold 45,500 Shares; New 6,500-Share Sale Planned

Rhea-AI Filing Summary

Form 144 notice for Blend Labs, Inc. (BLND)

This filing discloses a proposed sale of 6,500 common shares to be executed on 09/18/2025 through Charles Schwab & Co., with an aggregate market value listed as $27,918.00. The shares were acquired by the seller on 05/20/2024 via a restricted stock lapse as equity compensation from Blend Labs, Inc. The filing also reports prior sales by the same person, Winnie Ling, totaling 45,500 shares sold across seven transactions between 07/03/2025 and 09/05/2025, with aggregate gross proceeds of $169,091.00. The filer certifies no undisclosed material adverse information and follows Rule 144 disclosure requirements.

Positive

• Full Rule 144 compliance: The filer discloses acquisition, sale plan date, broker, and certification regarding material information.
• Transparency on prior sales: The filing lists seven recent transactions with dates and gross proceeds totaling $169,091.00.

Negative

• Significant insider selling: The filer sold 45,500 shares in the past three months, which may be viewed negatively by some investors.
• Concentration of dispositions: Multiple sales in a short timeframe could prompt questions about insider liquidity needs or sentiment.

Insights

Securities Analyst

TL;DR: Insider is selling shares acquired via equity compensation; recent sales are substantial in aggregate and fully disclosed under Rule 144.

The filing shows a proposed sale of 6,500 shares (market value $27,918) scheduled for 09/18/2025 and describes the acquisition as a restricted stock lapse on 05/20/2024. Material to investors is the scale of recent dispositions: 45,500 shares sold across seven trades from 07/03/2025 to 09/05/2025 with gross proceeds of $169,091. This indicates active liquidity events by the insider. The filing is procedural and meets Rule 144 transparency requirements but does not provide any commentary on motivation or company fundamentals.

Corporate Governance Expert

TL;DR: Disclosure is compliant and timely; repeated insider sales merit monitoring but filing contains no adverse disclosures about issuer operations.

The notice includes the required representation that the seller lacks undisclosed material adverse information and documents the source of securities as equity compensation. From a governance perspective, the pattern of multiple sales by the same individual over a short period is notable for stakeholder scrutiny but the filing itself contains no allegations, restrictions, or 10b5-1 plan details. All required elements for a Form 144 submission are present.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	6500	27918.00	255696747	09/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/20/2024	Restricted Stock Lapse	BLEND LABS, INC.			6500	05/20/2024	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Winnie Ling 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	07/03/2025	8000	28000.00
Winnie Ling 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	07/10/2025	4000	14160.00
Winnie Ling 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	07/24/2025	4000	14360.00
Winnie Ling 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	08/07/2025	4000	14477.00
Winnie Ling 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	08/22/2025	4000	14000.00
Winnie Ling 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	09/04/2025	4000	14031.00
Winnie Ling 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	09/05/2025	17500	70063.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for BLND disclose?

The filing discloses a proposed sale of 6,500 common shares scheduled for 09/18/2025, acquired on 05/20/2024 via restricted stock lapse, sold through Charles Schwab.

How many shares did the insider sell in the past three months?

The filing lists seven sales by Winnie Ling totaling 45,500 shares between 07/03/2025 and 09/05/2025.

What were the gross proceeds from the recent insider sales?

The aggregate gross proceeds reported for the seven transactions equal $169,091.00.

Who is the broker and where will the proposed sale occur?

The proposed sale is to be executed via Charles Schwab & Co., Inc. on the NYSE.

How were the 6,500 shares acquired?

The shares were acquired on 05/20/2024 as a restricted stock lapse from Blend Labs, Inc. and noted as equity compensation.